IN186976B - - Google Patents

Info

Publication number
IN186976B
IN186976B IN3761DE1997A IN186976B IN 186976 B IN186976 B IN 186976B IN 3761DE1997 A IN3761DE1997 A IN 3761DE1997A IN 186976 B IN186976 B IN 186976B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Antoine Caron
Bruno France
Olovier Nonnier
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of IN186976B publication Critical patent/IN186976B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN3761DE1997 1996-12-23 1997-12-23 IN186976B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615904A FR2757543B1 (fr) 1996-12-23 1996-12-23 Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues

Publications (1)

Publication Number Publication Date
IN186976B true IN186976B (en:Method) 2001-12-22

Family

ID=9499043

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3761DE1997 IN186976B (en:Method) 1996-12-23 1997-12-23

Country Status (38)

Country Link
EP (1) EP0950050B1 (en:Method)
JP (2) JP4499188B2 (en:Method)
KR (1) KR100586670B1 (en:Method)
CN (1) CN1129580C (en:Method)
AR (1) AR009672A1 (en:Method)
AT (1) ATE307802T1 (en:Method)
AU (1) AU736697B2 (en:Method)
BR (1) BR9714081A (en:Method)
CA (1) CA2275596C (en:Method)
CO (1) CO5070688A1 (en:Method)
CZ (1) CZ296689B6 (en:Method)
DE (1) DE69734460T2 (en:Method)
DK (1) DK0950050T3 (en:Method)
DZ (1) DZ2383A1 (en:Method)
EE (1) EE04188B1 (en:Method)
EG (1) EG21567A (en:Method)
ES (1) ES2251038T3 (en:Method)
FR (1) FR2757543B1 (en:Method)
HR (1) HRP970699B1 (en:Method)
HU (1) HU227425B1 (en:Method)
IL (1) IL129938A (en:Method)
IN (1) IN186976B (en:Method)
IS (1) IS2357B (en:Method)
MY (1) MY118015A (en:Method)
NO (1) NO312364B1 (en:Method)
NZ (1) NZ336130A (en:Method)
PL (1) PL190494B1 (en:Method)
RS (1) RS49882B (en:Method)
RU (1) RU2192416C2 (en:Method)
SA (1) SA98180971B1 (en:Method)
SI (1) SI0950050T1 (en:Method)
SK (1) SK285088B6 (en:Method)
TR (1) TR199901363T2 (en:Method)
TW (1) TW518322B (en:Method)
UA (1) UA60324C2 (en:Method)
UY (1) UY24825A1 (en:Method)
WO (1) WO1998028271A1 (en:Method)
ZA (1) ZA9711576B (en:Method)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757543B1 (fr) * 1996-12-23 1999-04-02 Sanofi Sa Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues
FR2782082B3 (fr) * 1998-08-05 2000-09-22 Sanofi Sa Formes cristallines de (r)-(+)-n-[[3-[1-benzoyl-3-(3,4- dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4 -yl]-n-methylacetamide (osanetant) et procede pour la preparation dudit compose
JP5504334B2 (ja) 2010-03-12 2014-05-28 株式会社日本触媒 吸水性樹脂の製造方法
EP2643294B1 (en) * 2011-04-15 2016-08-24 Emcure Pharmaceuticals Limited An improved rilpivirine process

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531707A1 (fr) * 1982-08-16 1984-02-17 Midy Spa Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
FR2757543B1 (fr) * 1996-12-23 1999-04-02 Sanofi Sa Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues

Also Published As

Publication number Publication date
SK82899A3 (en) 1999-12-10
RS49882B (sr) 2008-08-07
UA60324C2 (uk) 2003-10-15
FR2757543A1 (fr) 1998-06-26
KR100586670B1 (ko) 2006-06-07
WO1998028271A1 (fr) 1998-07-02
EE04188B1 (et) 2003-12-15
FR2757543B1 (fr) 1999-04-02
UY24825A1 (es) 1998-04-21
ES2251038T3 (es) 2006-04-16
TR199901363T2 (xx) 1999-08-23
EE9900264A (et) 2000-02-15
SK285088B6 (sk) 2006-06-01
JP2009197022A (ja) 2009-09-03
NO993076D0 (no) 1999-06-22
MY118015A (en) 2004-08-30
IL129938A (en) 2004-06-20
TW518322B (en) 2003-01-21
JP2001507012A (ja) 2001-05-29
HU227425B1 (en) 2011-05-30
JP4499188B2 (ja) 2010-07-07
AR009672A1 (es) 2000-04-26
ATE307802T1 (de) 2005-11-15
SI0950050T1 (sl) 2006-04-30
IL129938A0 (en) 2000-02-29
NO312364B1 (no) 2002-04-29
CA2275596A1 (en) 1998-07-02
YU28999A (sh) 2003-01-31
CN1129580C (zh) 2003-12-03
IS5076A (is) 1999-06-10
IS2357B (is) 2008-04-15
CA2275596C (en) 2005-10-11
NO993076L (no) 1999-06-22
NZ336130A (en) 2001-01-26
AU736697B2 (en) 2001-08-02
SA98180971B1 (ar) 2006-09-13
KR20000069504A (ko) 2000-11-25
HRP970699A2 (en) 1998-10-31
CO5070688A1 (es) 2001-08-28
DZ2383A1 (fr) 2002-12-28
EP0950050B1 (fr) 2005-10-26
PL190494B1 (pl) 2005-12-30
HUP0001387A2 (hu) 2000-09-28
DE69734460T2 (de) 2006-07-06
HK1024002A1 (en) 2000-09-29
BR9714081A (pt) 2000-05-09
ZA9711576B (en) 1998-06-25
DE69734460D1 (de) 2005-12-01
CZ296689B6 (cs) 2006-05-17
EP0950050A1 (fr) 1999-10-20
EG21567A (en) 2001-12-31
DK0950050T3 (da) 2006-01-23
HUP0001387A3 (en) 2002-03-28
CN1241180A (zh) 2000-01-12
PL334256A1 (en) 2000-02-14
AU5668498A (en) 1998-07-17
CZ229299A3 (cs) 1999-09-15
HRP970699B1 (en) 2007-03-31
RU2192416C2 (ru) 2002-11-10

Similar Documents

Publication Publication Date Title
AR026662A2 (en:Method)
BRPI9713914B8 (en:Method)
IN191881B (en:Method)
IN192126B (en:Method)
ITMI960512V0 (en:Method)
IN188940B (en:Method)
ITGO960006V0 (en:Method)
IN176118B (en:Method)
ITMI960597V0 (en:Method)
ITCT960018A0 (en:Method)
ITMI960502V0 (en:Method)
BR9603859A (en:Method)
BR7601346U (en:Method)
BR7600721U (en:Method)
CN3044170S (en:Method)
CN3043460S (en:Method)
CN3043415S (en:Method)
CN3043073S (en:Method)
CN3042193S (en:Method)
CN3040621S (en:Method)
CN3039811S (en:Method)
CN3039344S (en:Method)
CN3041228S (en:Method)
CN3043414S (en:Method)
CN3039217S (en:Method)